<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Colomb Med (Cali)</journal-id>
<journal-title-group>
<journal-title>Colombia Médica : CM</journal-title>
</journal-title-group>
<issn pub-type="ppub">0120-8322</issn>
<issn pub-type="epub">1657-9534</issn>
<publisher>
<publisher-name>Universidad del Valle</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31168168</article-id>
<article-id pub-id-type="pmc">6536042</article-id>
<article-id pub-id-type="doi">10.25100/cm.v50i1.3555</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report</article-title>
<trans-title-group xml:lang="es">
<trans-title>Síndrome de Wiedemann-Steiner por una nueva variante patogénica en KMT2A: reporte de un caso</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ramirez-Montaño</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pachajoa</surname>
<given-names>Harry</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1 </label>Universidad Icesi, Facultad de Ciencias de la Salud. Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER). Cali, Colombia. </aff>
<aff id="aff2">
<label>2</label> Fundación Clínica Valle del Lili. Cali, Colombia. </aff>
<author-notes>
<corresp id="c1">
Diana Ramirez-Montaño, MD, MSc.. Universidad Icesi. Calle 18 No. 122-135, bloque L. Cali, Colombia. Tel: (57) (2) 5552334 Ext: 4035. Email: <email>daramirez@icesi.edu.co</email></corresp>
<fn fn-type="COI-statement" id="fn1">
<p><bold>Conflict of interest:</bold> The authors declare that they have no conflict of interest.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-03-30" publication-format="electronic">
<day>30</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" publication-format="electronic">
<season>Jan-Mar</season>
<year>2019</year>
</pub-date>
<volume>50</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>45</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Universidad del Valle</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This article is distributed under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<sec>
<title>Case Description:</title>
<p> We report the case of a one-year-old girl who was diagnosed with Wiedemann-Steiner Syndrome based on the identification of a novel <italic>de novo</italic> frameshift mutation in the <italic>KMT2A</italic> gene by whole exome sequencing and supported by her clinical features.</p>
</sec>
<sec>
<title>Clinical Findings:</title>
<p>
<italic>KMT2A</italic> mutations cause Wiedemann-Steiner Syndrome, a very rare genetic disorder characterized by congenital hypertrichosis, short stature, intellectual disability, and distinct facial features. </p>
</sec>
<sec>
<title>Treatment and Outcome:</title>
<p> Whole exome sequencing identified a novel frameshift variant: c. 4177dupA (p.Ile1393Asnfs * 14) in <italic>KMT2A</italic>; this change generates an alteration of the specific binding to non-methylated CpG motifs of the DNA to the protein. The genotype and phenotype of the patient were compared with those of earlier reported patients in the literature. </p>
</sec>
<sec>
<title>Clinical Relevance:</title>
<p> In diseases with low frequency, it is necessary to establish a genotype-phenotype correlation that allows the establishment of therapeutic and follow-up goals. The phenotype comparation with other reported cases did not show differences attributable to sex or age among patients with Wiedemann-Steiner Syndrome. Whole exome sequencing allows identifying causality in conditions with high clinical and genetic heterogeneity like hypertrichosis.</p>
</sec>
</abstract>
<trans-abstract xml:lang="es">
<title>Resumen</title>
<sec>
<title>Descripción del caso:</title>
<p> Se reporta el caso de una paciente femenina de un año de edad, diagnosticada con Síndrome de Wiedemann-Steiner basado en la identificación de una nueva variante patogénica <italic>de novo</italic> de tipo frameshift en el gen <italic>KMT2A</italic> Mediante secuenciación de exoma usando el enfoque de trio, sumado a sus características clínicas. </p>
</sec>
<sec>
<title>Hallazgos clínicos: </title>
<p>las mutaciones en <italic>KMT2A</italic> causan el Síndrome de Wiedemann-Steiner, un desorden genético muy raro caracterizado por hipertricosis congénita, talla baja, retardo mental variable y fenotipo facial distintivo, los cuales se encuentran en la paciente reportada.</p>
</sec>
<sec>
<title>Resultado:</title>
<p> La Secuenciación de exoma completo encontró una variante de tipo frameshift: c.4177dupA (p. Ile1393Asn<italic>fs</italic> * 14) en <italic>KMT2A,</italic> este cambio a nivel génico genera una alteración de la unión específica a motivos CpG no metilados del DNA a la proteína. El genotipo y el fenotipo de la paciente fue comparado con los pacientes reportados previamente en la literatura. </p>
</sec>
<sec>
<title>Relevancia clínica: </title>
<p>En enfermedades con baja frecuencia como la aquí reportada es necesario establecer correlaciones genotipo-fenotipo que permitan establecer planes terapéuticos y de seguimiento. El análisis realizado no evidenció diferencias atribuibles a sexo o edad entre los pacientes diagnosticados con Síndrome de Weidemann-Steiner. La secuenciación de exoma permitió identificar causalidad en este caso, cuya característica principal de hipertricosis se asocia con alta heterogeneidad clínica y genética.</p>
</sec>
</trans-abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>Frameshift mutation</kwd>
<kwd>histone methyltransferases</kwd>
<kwd>hypertrichosis</kwd>
<kwd>intellectual disability</kwd>
<kwd>whole exome sequencing</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>Palabras clave:</title>
<kwd>Secuenciación del Exoma completo</kwd>
<kwd>Hipertricosis</kwd>
<kwd>Mutación frameshift, Metiltransferasa de histonas</kwd>
<kwd>Discapacidad intelectual</kwd>
</kwd-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="4"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="27"></ref-count>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The genetic basis of congenital hypertrichosis is still unknown. Non-androgenic excessive growth of terminal hair is associated with several rare genetic conditions <xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B2">
<sup>2</sup>
</xref>. One of them is the Wiedemann-Steiner Syndrome (WDSTS) (MIM # 605130), a rare autosomal dominant disorder described for the first time by Wiedemann <italic>et al</italic>. <xref ref-type="bibr" rid="B3">
<sup>3</sup>
</xref>, and defined as a syndrome in 2000 by Steiner et al <xref ref-type="bibr" rid="B4">
<sup>4</sup>
</xref>. This syndrome is characterized by deficiency of pre and postnatal growth, hypertrichosis cubiti or generalized hypertrichosis, psychomotor delay, intellectual disability with behavioral alterations and distinctive facial features with narrow nose, sinofris, ocular hypertelorism, long philtrum, short palpebral fissures, low set ears and an ogival palate. Other associated physical findings include dilation of the renal calyces, convergent strabismus and limb shortening <xref ref-type="bibr" rid="B3">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B4">
<sup>4</sup>
</xref>. To date, 26 patients with WDSTS have been reported in the global literature <xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B6">
<sup>6</sup>
</xref>, and only one of them is from Latin America <xref ref-type="bibr" rid="B7">
<sup>7</sup>
</xref>. Clinical overlap between WDSTS and other genetic syndromes with hypertrichosis such as Kabuki Syndrome (KS, MIM # 147920, 300867), Coffin-Siris Syndrome (CS, MIM # 135900), Pierpont Syndrome (PS, MIM # 602342) and Cornelia de Lange Syndrome (CdLS, MIM # 122470) <xref ref-type="bibr" rid="B2">
<sup>2</sup>
</xref> may complicate the diagnosis.</p>
<p>In 2012, Jones <italic>et al</italic>. <xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref> performed whole exome sequencing in six patients with hypertrichosis and clinical features of WDSTS and identified novel and <italic>de novo</italic> dominant mutations in the <italic>KMT2A gene</italic> (lysine methyltransferase 2A, known previously as MLL) in five of them. They concluded that haploinsufficiency and heterozygous mutations in this gene were the genetic causes of WDSTS. No differences were found for gender. The 49 pathogenic variants reported to date in LOVD 3.0 for the <italic>KMT2A</italic> gene (<ext-link ext-link-type="uri" xlink:href="https://databases.lovd.nl/shared/variants/KMT2A">https://databases.lovd.nl/shared/variants/KMT2A</ext-link>) correspond mostly to mutations that lead to prematurely truncated proteins <xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B6">
<sup>6</sup>
</xref>. These pathogenic variants in <italic>KMT2A</italic> are associated with defects in chromatin remodeling and, consequently, in the regulation of gene expression <xref ref-type="bibr" rid="B8">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B9">
<sup>9</sup>
</xref>.</p>
<p>At this stage, the complete phenotype of WDSTS is not understood fully. We report the case of a girl from Colombia with clinical features of WDSTS in whom we identified a not previously reported pathogenic variant of <italic>KMT2A</italic>. To establish a genotype-phenotype correlation as the major aim of this report, her clinical features are compared with previously reported WDSTS patients.</p>
</sec>
<sec sec-type="cases">
<title>Case Description</title>
<p>We describe the case of a 21-month-old female patient from southwest Colombia, who was the second child of a 34-year-old mother and a nonconsanguineous 36-year-old father, both without a significant family history. The mother’s pregnancy was uncomplicated, and prenatal ultrasounds were normal. A cesarean delivery was performed at 38 weeks because of the breech position of the baby. The birth weight was 3,324 g (48<sup>th</sup> centile). The baby showed spontaneous neonatal adaptation with APGAR 9 and 10 at 1 and 5 minutes, respectively. She was released jointly with her mother on the second day after birth.</p>
<p>At three months of age, she was assessed by a neuropediatrics service for generalized hypotonia associated with psychomotor development delay. At six months of age, a low weight and height were documented as well as generalized hypertrichosis. The occurrence of this neurological symptoms together with persistent hypertrichosis at 12 months led to an assessment by a pediatric endocrinologist, who ruled out an androgenic hormone disorder (normal testosterone levels, α-OH-progesterone and somatomedin). At that age, she was also assessed by a pediatric gastroenterologist who diagnosed moderate gastroesophageal reflux that required pharmacological management. Later, at 20 months of age, she presented with two episodes of urinary infection, one of them complicated by pyelonephritis. </p>
<p>Regarding her development, she achieved cephalic support at 12 months, and assisted sitting at 18 months. At the age of 21 months, she did not exhibit age-appropriate language development.</p>
<p>The paraclinical tests performed on the patient included Normal brain MRI performed at 10 months of age. A renal ultrasound, dimercapto succinic acid renal scan and voiding cystourethrography were performed at 20 months of age and were reported to be normal. Other studies performed at this time were karyotype, blood and urine metabolic screening, creatinine phosphokinase, complete blood count, fasting glucose test, transthoracic echocardiogram, auditory and visual evoked potentials; all of them were reported as normal. X-rays of the extremities performed at 21 months of age showed bilateral congenital hip dislocation.</p>
<p>At 21 months of age, she was referred for genetic assessment because of delayed psychomotor development, generalized hypotonia, low height, and hypertrichosis. Her weight was 8,7 kg (-2,2 SD) and her height was 72 cm (-3,83 SD). Physical examination revealed round facies, thick eyebrows, synophrys, long eyelashes, downslanted palpebral fissures, hypertelorism, long philtrum, Dennis Morgan folds, and excessive thick facial hair mainly in the frontal region (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Generalized hypertrichosis was present and more pronounced on the back and around the mammillae (<xref ref-type="fig" rid="f2">Fig. 2</xref>). Other findings included mild generalized hypotonia, broad feet, and irritability without hyperactivity. </p>
<p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Facial appearance of one-year-old girl with Wiedemann-Steiner Syndrome<bold>.</bold> frontal hypertrichosis, low anterior hairline, thick eyebrows, synophrys, long eyelashes, hypertelorism, left palpebral ptosis, epicanthic folds, downslanted palpebral fissures, low set ears, and wide and depressed nasal bridge.</title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf1"></graphic></fig>
</p>
<p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Physical appearance of one-year-old girl with Wiedemann-Steiner Syndrome: generalized hypertrichosis predominantly around the midline and low back region.</title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf2"></graphic></fig>
</p>
<p>Further investigation was performed using whole exome sequencing (WES) in the trio approach with a massive sequencing platform (CeGaT-GmbH, Tübingen, Germany). WES was performed on the sequencing coding and flanking intronic regions using the HiSeq2500/4000 system (Illumina®, San Diego, CA, US). The CASAVA 1.8 analysis package (Illumina®, San Diego, CA, US) was used to demultiplex the sequencing reads. The trimmed reads were mapped to the human reference genome (GRCh38) using the Burrows-Wheeler aligner software. A novel frameshift pathogenic variant in the heterozygous state of the <italic>KMT2A</italic> gene (v1. NM_001197104.1) was identified: c. 4177dupA (p. Ile1393Asnfs*14). This variant was not identified in either of the patient’s parents and has not been reported previously in population databases. This variant generates a change in the reading frame that results in the premature truncation of the protein or degradation of the messenger RNA. This finding was confirmed by Sanger sequencing and was compatible with the diagnosis of WDSTS. No other gene variants were identified in this case.</p>
<p>According to the American College of Medical Genetics and Genomics (ACMG) Guidelines for the Interpretation of Sequence Variants <xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref>, this variant is classified as pathogenic (PVS1, PS2, PM2, and PP3 criteria). The variant functional prediction software tools SIFT (https://sift.bii.a-star.edu.sg/), Functional Analysis through Hidden Markov Models FATHMM (<ext-link ext-link-type="uri" xlink:href="http://fathmm.biocompute.org.uk/">http://fathmm.biocompute.org.uk/</ext-link>) and Polymorphism Phenotyping v2 (Polyphen-2 http: // genetics. bwh.harvard.edu/pph2/) classified it as a deleterious/damaging variant (disease causing) because of its high evolutionary conservation.</p>
<p>The <italic>de novo</italic> inheritance of the mutation was explained to her parents, as was the recurrence risk that varies from 3% to 5% in future pregnancies <xref ref-type="bibr" rid="B11">
<sup>11</sup>
</xref>. The patient's follow-up plan includes annual renal and cardiac tests to assess other syndrome-associated features that may not yet be present in the patient due to the young age of the diagnosis. Neurological follow-up includes a therapy intervention for the hypotonia and the possible intellectual commitment.</p>
<p>The patient’s parents provided written informed consent for the publication of her case report and accompanying images.</p>
</sec>
<sec sec-type="discussion">
<title>Discussion </title>
<p>Exome sequencing has revolutionized the genetic study of monogenic diseases over the last decade. This diagnostic tool allows the time- and cost-effective sequencing of the whole exome (approx. 3% of the genome) to identify genetic causes of dysmorphological syndromes with high clinical and genetic heterogeneity. Exome sequencing has improved diagnostic performance in medical genetic practice by more than 25%, leading to a better understanding of molecular mechanisms involved in pathologies with Mendelian inheritance <xref ref-type="bibr" rid="B12">
<sup><italic>12</italic></sup>
</xref>. This method has enabled the identification of new genes responsible for unclear cases that had remained without diagnosis previously, and of new syndromes involved in human disease <xref ref-type="bibr" rid="B12">
<sup><italic>12</italic></sup>
</xref>.</p>
<p>WDSTS is one of the new syndromes identified by exome sequencing since 2012 <xref ref-type="bibr" rid="B1">
<sup><italic>1</italic></sup>
</xref>. Its clinical features overlap with other syndromes that present with hypertrichosis <xref ref-type="bibr" rid="B13">
<sup><italic>13</italic></sup>
</xref>. Pathogenic variants in the <italic>KMT2A</italic> gene have been identified as a cause of this syndrome in studies with large sample sizes that validate the clinical utility of next-generation sequencing tools <xref ref-type="bibr" rid="B14">
<sup><italic>14</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B15">
<sup><italic>15</italic></sup>
</xref>. The recurrent appearance of recently characterized genes in these studies is probably due to the previous unavailability of clinical tests for gene analysis either individually or as part of a multigenic panel that included the new loci associated with WDSTS <xref ref-type="bibr" rid="B14">
<sup><italic>14</italic></sup>
</xref>. </p>
<p>It is challenging to diagnose WDSTS because the phenotype shows extensive variation and is not defined clearly. In the young female patient reported here, the facial features appear to be similar to patients reported in other studies. Synophrys, long eyelashes, ocular hypertelorism and long philtrum <xref ref-type="bibr" rid="B1">
<sup><italic>1</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup><italic>5</italic></sup>
</xref> are characteristic for all of them. While they may appear as early as one year of age, they become accentuated with age <xref ref-type="bibr" rid="B16">
<sup><italic>16</italic></sup>
</xref>. Other features include generalized hypertrichosis that has been reported in more than 80% of WDSTS patients, and was prominent at the back in our case <xref ref-type="bibr" rid="B1">
<sup><italic>1</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup><italic>5</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B6">
<sup><italic>6</italic></sup>
</xref>. Hypertrichosis cubiti is frequently associated with this syndrome and is considered the most prominent feature, but was not present in our patient. Prenatal growth retardation reported by other authors <xref ref-type="bibr" rid="B1">
<sup><italic>1</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B3">
<sup><italic>3</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup><italic>5</italic></sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B6">
<sup><italic>6</italic></sup>
</xref>
and microcephaly, seen in 50% of patients with WDSTS, were not present either <xref ref-type="bibr" rid="B5">
<sup><italic>5</italic></sup>
</xref>. <xref ref-type="table" rid="t1">Table 1</xref> summarizes the phenotypic characteristics of our patient as compared to what is described in the literature for other patients with WDSTS.</p>
<p>
<table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Summary of phenotypic features in 1-year old female patient compared to features present in more than 60% of patients with WDSTS. </title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th align="justify" colspan="1" rowspan="1">Clinical features present in patient in this case report</th><th align="center" colspan="1" rowspan="1">% of patients with WDSTS that exhibit the feature</th></tr></thead><tbody><tr><td align="justify" colspan="1" rowspan="1">Postnatal growth retardation</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="justify" colspan="1" rowspan="1">Psychomotor development delay</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="justify" colspan="1" rowspan="1">Intellectual disability (variable)</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="justify" colspan="1" rowspan="1">Depressed nasal bridge</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="justify" colspan="1" rowspan="1">Bulbous nose</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="justify" colspan="1" rowspan="1">Long eyelashes</td><td align="center" colspan="1" rowspan="1">94.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Wide nasal bridge</td><td align="center" colspan="1" rowspan="1">89.5</td></tr><tr><td align="justify" colspan="1" rowspan="1">Downslanted palpebral fissures </td><td align="center" colspan="1" rowspan="1">88.9</td></tr><tr><td align="justify" colspan="1" rowspan="1">Thick hair</td><td align="center" colspan="1" rowspan="1">85.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Prominent digital pads</td><td align="center" colspan="1" rowspan="1">83.3</td></tr><tr><td align="justify" colspan="1" rowspan="1">Dorsal hypertrichosis</td><td align="center" colspan="1" rowspan="1">83.3</td></tr><tr><td align="justify" colspan="1" rowspan="1">Low anterior hairline</td><td align="center" colspan="1" rowspan="1">75.0</td></tr><tr><td align="justify" colspan="1" rowspan="1">Broad nasal tip</td><td align="center" colspan="1" rowspan="1">73.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Thick eyebrows</td><td align="center" colspan="1" rowspan="1">71.4</td></tr><tr><td align="justify" colspan="1" rowspan="1">Hypertelorism</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Hypotonia</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Palpebral ptosis</td><td align="center" colspan="1" rowspan="1">63.6</td></tr><tr><td align="justify" colspan="1" rowspan="1">Clinical features not present in patient in this case report</td><td align="center" colspan="1" rowspan="1">% of patients with WDSTS that exhibit the feature</td></tr><tr><td align="justify" colspan="1" rowspan="1">High palate</td><td align="center" colspan="1" rowspan="1">88.3</td></tr><tr><td align="justify" colspan="1" rowspan="1">Prenatal growth retardation</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Short columela </td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Macroglossia</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Single transverse palmar crease</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="justify" colspan="1" rowspan="1">Small hands and feets</td><td align="center" colspan="1" rowspan="1">63.6</td></tr><tr><td align="justify" colspan="1" rowspan="1">Clinodactyly</td><td align="center" colspan="1" rowspan="1">60.0</td></tr></tbody></table></table-wrap>
</p>
<p>Neurological manifestations reported in WDSTS include intellectual disability and psychomotor development delay that are present in 100% of patients, and hypotonia, which can be found in 66.7%. Both of these features were present in our patient. She also exhibited a speech and language developmental delay. Because of her age, an IQ test was not performed. Irritability is a prominent feature in the behavior of WDSTS patients and has been reported in about 20% in combination with hyperactivity, heteroagression, and autistic features <xref ref-type="bibr" rid="B17">
<sup>17</sup>
</xref>. Our patient also presented congenital bilateral hip dislocation that has been reported in 34% of patients with WDSTS <xref ref-type="bibr" rid="B11">
<sup>11</sup>
</xref>. Other features that were reported previously but were ruled out in our patient are feeding problems (58%), urinary system anomalies (34%) and cardiac abnormalities (31.3%) associated with high morbidity <xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B17">
<sup>17</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B18">
<sup>18</sup>
</xref>.</p>
<p>The <italic>KMT2A</italic> gene encodes a histone methyltransferase related to the regulation of gene expression. This protein plays an essential role in the DNA packaging for early development and hematopoiesis, mediating chromatin modifications associated with epigenetic transcriptional activation. The <italic>KMT2A</italic> gene shows broad expression in almost all human tissues <xref ref-type="bibr" rid="B14">
<sup>14</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B15">
<sup>15</sup>
</xref> and contains 36 exons that encode different isoforms (Ref Seq 2010). The mutations reported in WDSTS so far have all been <italic>de novo</italic>, meaning a new variant is reported with each clinical report. The majority of mutations are nonsense, frameshift, splice site deletion, or exon deletion, leading to a truncated transcript (messenger RNA) or protein. The mutation reported here c.4177dupA (p.Ile1393Asnfs * 14) is not annotated in the 1,000 Genomes Project, ExAC, or EVSor in-house database, and, so far, has not been reported in the literature. Frameshift type mutations, such as this one, constitute very strong pathogenic criteria according to the ACMG classification of sequencing variants, because they modify the length of the protein by inserting premature stop codons with the shift of the reading frame; therefore, it is usually related to severe phenotypes in monogenic diseases <xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref>.</p>
<p>The pathogenic variants in the <italic>KMT2A</italic> gene that cause WDSTS are distributed throughout the gene, but located before the FYRC domain. This domain is important for the recognition of a protein after cleavage. More than 50% of reported mutations have been in exons 3 and 27, the two longest exons of this gene; however, mutational hot-spot sites have not been identified <xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref>. Our patient showed a pathogenic variant in exon 9, between two conserved domains of this protein, the cysteine-rich CXXC, homologous to the DNA metil transferase domain, and the Plant Homeodomain finger (PHD) motif (<xref ref-type="fig" rid="f3">Fig. 3</xref>). Both these domains allow specific binding to non-methylated CpG DNA motifs, essential for gene recognition, transactivation and transformation associated with MLL proteins <xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref>. There is only one patient with a similar mutation, who was reported by Mendelsohn et al <xref ref-type="bibr" rid="B20">
<sup>20</sup>
</xref>. Their patient had an intragenic deletion of exons 2-10 (<xref ref-type="table" rid="t2">Table 2</xref>). This patient had recurrent urinary tract infections and renal alterations. Our patient also had two episodes of urinary tract infections, one of them complicated by pyelonephritis at the age of 20 months. A nephrology assessment ruled out renal alteration; however, it is a current recommendation to perform regular renal ultrasound in the follow-up of patients with WDSTS <xref ref-type="bibr" rid="B6">
<sup>6</sup>
</xref>. The heterozygous state of the variant with autosomal dominant inheritance acts like a null allele that leads to a prematurely truncated protein interfering with the normal protein. This is similar to what is reported in the literature when a null or missing allele have a negative dominant effect over the normal allele <xref ref-type="bibr" rid="B6">
<sup>6</sup>
</xref>.</p>
<p>
<fig id="f3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>A. Location of reported KMT2A mutation: Electrophogram of exon 9 of the <italic>KMT2A</italic> gene showed duplication of adenine (blue arrow) at position 4177 <bold>c.</bold>4177dupA. This has a frameshift effect, generating a premature stop at codon 13 positions later (red box). B. Position at the protein level: The mutation leads to premature termination of the translation before the c-terminal region (black arrow) that contains the BD domain, transactivation domain and SET domain, as PHD motifs that are essential for gene recognition, transactivation and transformation associated with protein function. FRYN, FYRC, and Win motifs are not expressed either.</title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf3"></graphic></fig>
</p>
<p>
<table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Summary of mutations in the <italic>KMT2A</italic> gene in patients with WDSTS in the literature. </title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Patients</th><th align="left" colspan="1" rowspan="1"> Amino acid change </th><th align="justify" colspan="1" rowspan="1"> Affected gene region </th><th align="left" colspan="1" rowspan="1"> Ethnicity </th><th align="left" colspan="1" rowspan="1">Author</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">WDST1</td><td align="justify" colspan="1" rowspan="1">p.V2936* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> Not reported </td><td align="left" colspan="1" rowspan="5">Jones et al.
<xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">WDST2</td><td align="justify" colspan="1" rowspan="1">p.L2756* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1">WDST3</td><td align="justify" colspan="1" rowspan="1">p.S2305Lfs*2 </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1">WDST5</td><td align="justify" colspan="1" rowspan="1">p.R2382*</td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1">WDST6</td><td align="justify" colspan="1" rowspan="1">p.K1534* </td><td align="justify" colspan="1" rowspan="1">Exon 13</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1">Patient 1</td><td align="justify" colspan="1" rowspan="1">p.C1448R </td><td align="justify" colspan="1" rowspan="1">Exon 11</td><td align="left" colspan="1" rowspan="1">Mexican</td><td align="left" colspan="1" rowspan="2">Strom et al.
<xref ref-type="bibr" rid="B7">
<sup>7</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Patient 2</td><td align="justify" colspan="1" rowspan="1">c.4086+1G&gt;A </td><td align="justify" colspan="1" rowspan="1">Intron 8</td><td align="left" colspan="1" rowspan="1">Caucasian</td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">chr11:118,339,487-118,355,089del </td><td align="justify" colspan="1" rowspan="1">Exon 2 to 10</td><td align="left" colspan="1" rowspan="1">Hispanic</td><td align="left" colspan="1" rowspan="1">Mendelson et al.
<xref ref-type="bibr" rid="B20">
<sup>20</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">P1</td><td align="justify" colspan="1" rowspan="1">p.G2422* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> Not reported </td><td align="left" colspan="1" rowspan="2">Zemojtel et al.
<xref ref-type="bibr" rid="B21">
<sup>21</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">P8</td><td align="justify" colspan="1" rowspan="1">p.E3448fs*7 </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">p.R2127* </td><td align="justify" colspan="1" rowspan="1">Exon 26</td><td align="left" colspan="1" rowspan="1"> Not reported </td><td align="left" colspan="1" rowspan="1">Calvel et al.
<xref ref-type="bibr" rid="B22">
<sup>22</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1"> Twin 1</td><td align="justify" colspan="1" rowspan="1">p.R1083* </td><td align="justify" colspan="1" rowspan="1">Exon 4</td><td align="left" colspan="1" rowspan="1">Caucasian</td><td align="left" colspan="1" rowspan="2">Dunkerton et al.
<xref ref-type="bibr" rid="B18">
<sup>18</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1"> Twin 2</td><td align="justify" colspan="1" rowspan="1">p.R1083* </td><td align="justify" colspan="1" rowspan="1">Exon 4</td><td align="left" colspan="1" rowspan="1"> </td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">p.R1636* </td><td align="justify" colspan="1" rowspan="1">Exon 15</td><td align="left" colspan="1" rowspan="1">Arabian</td><td align="left" colspan="1" rowspan="1">Steel et al.
<xref ref-type="bibr" rid="B23">
<sup>23</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Patient 1</td><td align="justify" colspan="1" rowspan="1">p.R2480* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1">Japanese </td><td align="left" colspan="1" rowspan="6">Miyake et al.
<xref ref-type="bibr" rid="B24">
<sup>24</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1"> Patient 2</td><td align="justify" colspan="1" rowspan="1">p.Q2261* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1">Japanese</td></tr><tr><td align="left" colspan="1" rowspan="1"> Patient 3</td><td align="justify" colspan="1" rowspan="1">p.C1189Y </td><td align="left" colspan="1" rowspan="1">Exon 5</td><td align="left" colspan="1" rowspan="1">Australian</td></tr><tr><td align="left" colspan="1" rowspan="1"> Patient 4</td><td align="justify" colspan="1" rowspan="1">p.Pro280Thr </td><td align="left" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Japanese</td></tr><tr><td align="left" colspan="1" rowspan="1"> Patient 5</td><td align="justify" colspan="1" rowspan="1">p.V347Lfs*53</td><td align="justify" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Japanese</td></tr><tr><td align="left" colspan="1" rowspan="1"> Patient 6</td><td align="justify" colspan="1" rowspan="1">p.L717Cfs*39 </td><td align="justify" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Japanese</td></tr><tr><td align="left" colspan="1" rowspan="1">CdLS 3</td><td align="justify" colspan="1" rowspan="1">p.R745* </td><td align="justify" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Turkish</td><td align="left" colspan="1" rowspan="1">Yuan et al.
<xref ref-type="bibr" rid="B25">
<sup>25</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">p.C1161G </td><td align="justify" colspan="1" rowspan="1">Exon 5</td><td align="left" colspan="1" rowspan="1">Italian</td><td align="left" colspan="1" rowspan="1">Stellacci et al.
<xref ref-type="bibr" rid="B26">
<sup>26</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">A.II-5</td><td align="justify" colspan="1" rowspan="1">p.Q2803* </td><td align="justify" colspan="1" rowspan="1">Exon 27</td><td align="left" colspan="1" rowspan="1">Chinese</td><td align="left" colspan="1" rowspan="2">Sun et al.
<xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1">B.II-1</td><td align="justify" colspan="1" rowspan="1">p.Q819* </td><td align="justify" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Chinese</td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">p. Pro51Argfs*84 </td><td align="justify" colspan="1" rowspan="1">Exon 1</td><td align="left" colspan="1" rowspan="1"> Not reported </td><td align="left" colspan="1" rowspan="1">Argawall et al.
<xref ref-type="bibr" rid="B27">
<sup>27</sup>
</xref>
</td></tr><tr><td align="left" colspan="1" rowspan="1"> </td><td align="justify" colspan="1" rowspan="1">p. Ile1393Asn<italic>fs</italic>*14 </td><td align="justify" colspan="1" rowspan="1">Exon 9</td><td align="left" colspan="1" rowspan="1">Colombian</td><td align="left" colspan="1" rowspan="1"> This report </td></tr></tbody></table></table-wrap>
</p>
<p>In summary, we reported the first case of a patient from Colombia with a frameshift pathogenic variant not reported previously in the <italic>KMT2A</italic> gene. The phenotype was similar to what is reported in the worldwide literature. This 1-year-old patient had a clinical history of urinary infection episodes without renal impairment or pathological findings in imaging, which seems to be related to the methyltransferase activity of the protein located in the domains and motifs affected by the mutation as described here. </p>
<p>This report is an approach to a possible genotype-phenotype correlation for WDSTS, in which, in case of hypertrichosis, neurological and renal involvement must always be ruled out. The most prominent features of WDSTS that can serve as diagnostic criteria are generalized hypertrichosis, postnatal growth retardation, psychomotor development delay and distinct facial phenotype (thick hair and eyebrows, hypertelorism, downslanted palpebral fissures, and long eyelashes). In more than 70% of the patients reported in the literature, these features are present.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dafou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McEntagart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Woollard</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Elmslie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Holder-Espinasse</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>De Novo mutations in MLL cause Wiedemann-Steiner syndrome</article-title>
<source/>Am J Hum Genet
          <year>2012</year>
<volume>91</volume>
<issue>2</issue>
<fpage>358</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.06.008</pub-id>
<pub-id pub-id-type="pmid">22795537</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Praticò</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falsaperla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ruggieri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zollino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corsello</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Congenital generalized hypertrichosis the skin as a clue to complex malformation syndromes</article-title>
<source/>Ital J Pediatr
          <year>2015</year>
<volume>41</volume>
<issue>1</issue>
<fpage>55</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1186/s13052-015-0161-3</pub-id>
<pub-id pub-id-type="pmid">26242548</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wiedemann</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Kunze</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grosse</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Dibbern</surname>
<given-names>H</given-names>
</name>
</person-group>
<chapter-title>A syndrome of abnormal facies, short stature, and psychomotor retardation</chapter-title>
<source/>Atlas of clinical syndromes: a visual aid to diagnosis for clinicians and practicing physicians
          <edition>2nd ed</edition>
<publisher-loc>London</publisher-loc>
<publisher-name>Wolfe Publishing Ltd.</publisher-name>
<year>1992</year>
<fpage>198</fpage>
<lpage>199</lpage>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steiner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Growth deficiency, mental retardation and unusual facies</article-title>
<source/>Clin Dysmorphol
          <year>2000</year>
<volume>9</volume>
<issue>2</issue>
<fpage>155</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1097/00019605-200009020-00021</pub-id>
<pub-id pub-id-type="pmid">10826636</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Further delineation of the phenotype of truncating KMT2Amutations The extended Wiedemann-Steiner syndrome</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>173</volume>
<issue>2</issue>
<fpage>510</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.38025</pub-id>
<pub-id pub-id-type="pmid">27759909</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Rodriguez-Buritica DF, Northrup H Wiedemann-Steiner syndrome: novel pathogenic variant and review of literature</article-title>
<source/>Eur J Med Genet
          <year>2017</year>
<volume>60</volume>
<issue>6</issue>
<fpage>285</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2017.03.006</pub-id>
<pub-id pub-id-type="pmid">28359930</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strom</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dorrani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O´Lague</surname>
<given-names>PF</given-names>
</name>
</person-group>
<article-title>De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing</article-title>
<source/>BMC Medical Genetics
          <year>2014</year>
<volume>15</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-15-49</pub-id>
<pub-id pub-id-type="pmid">24886118</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milne</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Briggs</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Brock</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>MLL targets SET domain methyltransferase activity to Hox gene promoters</article-title>
<source/>Molecular Cell
          <year>2002</year>
<volume>10</volume>
<fpage>1107</fpage>
<lpage>1117</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(02)00741-4</pub-id>
<pub-id pub-id-type="pmid">12453418</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krajewski</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rozovskaia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wassell</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>2002 ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation</article-title>
<source/>Molecular Cell
          <year>2002</year>
<volume>10</volume>
<fpage>1119</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(02)00740-2</pub-id>
<pub-id pub-id-type="pmid">12453419</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Standards and guidelines for the interpretation of sequence variants a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology</article-title>
<source/>Genet Med
          <year>2015</year>
<volume>17</volume>
<issue>5</issue>
<fpage>405</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
</person-group>
<source/>Basiswissen Humangenetik, 2. Aufl
          <year>2013</year>
<publisher-loc>Berlin/Heidelberg</publisher-loc>
<publisher-name>Springer Verlag</publisher-name>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Diagnostic clinical genome and exome sequencing</article-title>
<source/>N Engl J Med
          <year>2014</year>
<volume>371</volume>
<issue>12</issue>
<fpage>1170</fpage>
<lpage>1170</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1408914</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bramswig</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Lüdecke</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Alanay</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Barthelmie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boduroglu</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Exome sequencing unravels unexpected differential diagnoses in individuals with the tentative diagnosis of Coffin-Siris and Nicolaides-Baraitser syndromes</article-title>
<source/>Human Genetics
          <year>2015</year>
<volume>134</volume>
<issue>6</issue>
<fpage>553</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-015-1535-8</pub-id>
<pub-id pub-id-type="pmid">25724810</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farwell</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Shahmirzadi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>El-Khechen</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Enhanced utility of familycentered diagnostic exome sequencing with inheritance model-based analysis results from 500 unselected families with undiagnosed genetic conditions</article-title>
<source/>Genet Med
          <year>2015</year>
<volume>17</volume>
<fpage>578</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2014.154</pub-id>
<pub-id pub-id-type="pmid">25356970</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Muzny</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>
<source/>JAMA
          <year>2014</year>
<volume>312</volume>
<fpage>1870</fpage>
<lpage>1879</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.14601</pub-id>
<pub-id pub-id-type="pmid">25326635</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koenig</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meinecke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Wiedemann-Steiner syndrome three further cases</article-title>
<source/>Am J Med Genet A
          <year>2010</year>
<volume>152A</volume>
<issue>9</issue>
<fpage>2372</fpage>
<lpage>2375</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33587</pub-id>
<pub-id pub-id-type="pmid">20803650</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Genetic studies in intellectual disability and related disorders</article-title>
<source/>Nat Rev Genet
          <year>2016</year>
<volume>17</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3999</pub-id>
<pub-id pub-id-type="pmid">26503795</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunkerton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Field</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bertram</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Whittle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Groves</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A de novo Pathogenic variant in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167A</volume>
<issue>9</issue>
<fpage>2182</fpage>
<lpage>2187</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37130</pub-id>
<pub-id pub-id-type="pmid">25929198</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cleary</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein</article-title>
<source/>Mol Cellular Biol
          <year>2004</year>
<volume>24</volume>
<issue>23</issue>
<fpage>10470</fpage>
<lpage>10478</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.24.23.10470-10478.2004</pub-id>
<pub-id pub-id-type="pmid">15542854</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendelsohn</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Pronold</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smaoui</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Slavotinek</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A (MLL)</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>8</issue>
<fpage>2079</fpage>
<lpage>2083</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36590</pub-id>
<pub-id pub-id-type="pmid">24818805</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zemojtel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Köhler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mackenroth</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jäger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krawitz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome</article-title>
<source/>Sci Transl Med
          <year>2014</year>
<volume>6</volume>
<fpage>252ra123</fpage>
<lpage>252ra123</lpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009262</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kusz-Zamelczyk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Makrythanasis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Janecki</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Borel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Conne</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>A Case of Wiedemann-Steiner Syndrome Associated with a 46,XY Disorder of Sexual Development and Gonadal Dysgenesis</article-title>
<source/>Sexual Development
          <year>2015</year>
<volume>9</volume>
<issue>5</issue>
<fpage>289</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.1159/000441512</pub-id>
<pub-id pub-id-type="pmid">26544196</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Salpietro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Phadke</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pitt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Massoud</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Whole exome sequencing reveals a MLL de novo mutation associated with mild developmental delay and without &amp;apos;hairy elbows&amp;apos; expanding the phenotype of Wiedemann-Steiner syndrome</article-title>
<source/>J Gen
          <year>2015</year>
<volume>94</volume>
<issue>4</issue>
<fpage>755</fpage>
<lpage>758</lpage>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Koshimizu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kosho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations</article-title>
<source/>Clin Gen
          <year>2016</year>
<volume>89</volume>
<issue>1</issue>
<fpage>115</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12586</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Karaca</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Charng</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes</article-title>
<source/>J Clin Invest
          <year>2015</year>
<volume>125</volume>
<issue>2</issue>
<fpage>636</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12586</pub-id>
<pub-id pub-id-type="pmid">25574841</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stellacci</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Onesimo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bruselles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pizzi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Leoni</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Congenital immunodeficiency in an individual with Wiedemann-Steiner syndrome due to a novel missense mutation in KMT2A</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<issue>9</issue>
<fpage>2389</fpage>
<lpage>2393</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37681</pub-id>
<pub-id pub-id-type="pmid">27320412</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argawall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodriguez-Buritica</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Northrup</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Wiedemann-Steiner syndrome: Novel pathogenic variant and review of literature</article-title>
<source/>Eur J Med Genet
          <year>2017</year>
<volume>60</volume>
<issue>6</issue>
<fpage>285</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2017.03.006</pub-id>
<pub-id pub-id-type="pmid">28359930</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<sub-article article-type="case report" id="s1" xml:lang="es">
<front-stub>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reporte De Caso</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Síndrome de Wiedemann-Steiner por una nueva variante patogénica en KMT2A: reporte de un caso</article-title>
</title-group>
<author-notes>
<fn fn-type="COI-statement" id="fn2">
<p><bold>Conflictos de interés: </bold> Los autores declaran que no existe conflicto de interés</p>
</fn>
</author-notes>
</front-stub>
<body>
<sec sec-type="intro">
<title>Introducción</title>
<p>Las bases genéticas de la hipertricosis congénita aún son desconocidas, el crecimiento excesivo del vello terminal no relacionado con andrógenos se asocia a varias condiciones genéticas raros <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref>. Uno de ellos es el síndrome de Wiedemann-Steiner (SWS) (MIM #605130), un trastorno autosómico dominante raro descrito por primera vez por Wiedemann et al.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>, y definido como síndrome en el 2000 por Steiner <italic>et al</italic><xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. Este síndrome es caracterizado por deficiencia de crecimiento pre y postnatal, hipertricosis cubiti o generalizada, retraso psicomotor, discapacidad intelectual con alteraciones del comportamiento y facies características con nariz estrecha, sinofris, hipertelorismo ocular, filtrum largo, fisuras palpebrales cortas, orejas de implantación baja y paladar ojival. Otros hallazgos asociados incluyen dilatación de calices renales, estrabismo convergente y acortamiento de extremidades <xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. Se han reportado hasta el momento 26 pacientes en la literatura global con características del SWS <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>, de los cuales solo un paciente es originario de américa Latina <xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. Las características de este síndrome se sobrelapan con otros síndromes asociados a Hipertricosis como Kabuki Syndrome (KS, MIM 147920, 300867), Coffin Siris (CS, MIM 135900), Pierpont Syndrome (PS, MIM 602342) y Cornelia de Lange syndrome (CdLS, MIM 122470) <xref ref-type="bibr" rid="B2"><sup>2</sup></xref> lo que puede dificultar su diagnóstico.</p>
<p>En el año 2012, Jones <italic>et al</italic>.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>, realizaron secuenciación exómica (<italic>Whole exome secuencing</italic>) de pacientes con características clínicas del SWS identificando mutaciones en estado heterocigoto <italic>de novo</italic> en el gen <italic>KMT2A</italic> (antes conocido como MLL) en cinco de seis pacientes y concluyendo que la haploinsuficiencia de este gen era la causa genética de esta entidad . Hasta el momento no se han encontrado diferencias en género, las 49 variantes patogénicas reportadas hasta el momento en LOVD 3.0 para el gen (<ext-link ext-link-type="uri" xlink:href="https://databases.lovd.nl/shared/variants/KMT2A">https://databases.lovd.nl/shared/variants/KMT2A</ext-link>) corresponden en su mayoría a mutaciones <italic>de novo</italic> que generalmente conducen a proteínas truncadas prematuramente <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. Estas variantes en <italic>KMT2A</italic> generan defectos en la remodelación de la cromatina que participa en la regulación de la expresión génica <xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>.</p>
<p>El fenotipo completo del SWS no se entiende completamente. Se presenta una paciente de origen colombiano con esta entidad, quien además presenta una variante patogénica no reportada en <italic>KMT2A,</italic> y se comparan sus características clínicas con los pacientes reportados previamente tratando de establecer una correlación genotipo-fenotipo.</p>
</sec>
<sec sec-type="cases">
<title>Reporte de caso</title>
<p>Paciente femenina de 21 meses de edad, producto de la segunda gestación de la madre. La madre con 34 años y el padre con 36 años no consanguíneos. No hay historia familiar significativa. Embarazo normal con ultrasonidos prenatales normales. Parto por cesárea a las 38 semanas de gestación, debido a presentación podálica del feto. Peso al nacer: 3,324 g (Percentil 48), adaptación neonatal espontanea con APGAR 9-10 al 1 y 5 minutos, respectivamente. Fue dada de alta conjunta con su madre al segundo día de nacida.</p>
<p>La niña fue valorada al tercer mes de edad por neuropediatría por el cuadro clínico de hipotonía generalizada, asociado a un retraso en el desarrollo psicomotor. Desde los 6 meses de edad se documentaron un bajo peso y talla. Debido a la asociación del cuadro neurológico con hipertricosis, fue valorada a la edad de 12 meses, por endocrinología pediátrica quienes descartaron un trastorno hormonal de tipo androgénico (Niveles de testosterona, α-OH-progesterona y Somatomedina normales). A esa misma edad fue valorada por gastroenterología y nutrición debido al bajo peso quienes diagnosticaron un reflujo gastroesofágico moderado que requirió un manejo farmacológico. Adicionalmente, a la edad de 20 meses, presentó dos episodios de infección urinaria, uno de ellos complicado con pielonefritis. El desarrollo psicomotor de la paciente fue retrasado, logró el sostén cefálico a los 12 meses, sedestación asistida a los 18 meses y hasta la edad de 21 meses no había un desarrollo del lenguaje. </p>
<p>Los paraclínicos realizados incluyen: Resonancia magnética cerebral realizada a los 10 meses de edad con resultado normal. Ecografía renal, DMSA y Cistografía miccional realizadas a los 20 meses, normales. Otros estudios realizados a la edad de 20 meses fueron Cariotipo, tamizaje metabólico en sangre y orina, CPK, hemograma, glicemia en ayunas, ecocardiograma, potenciales evocados auditivos y visuales, todos reportados como normales. Las radiografías de extremidades realizadas a la misma edad evidenciaron luxación congénita bilateral de la cadera.</p>
<p>Fue referida para evaluación genética debido a la historia del retraso del desarrollo, hipotonía y baja talla. Al momento de la valoración, a los 21 meses de edad, el peso fue de 8.7 kg (-2.2 DE), altura 72 cm (-3.83 DE) y circunferencia de la cabeza de 47.2 cm (Percentil 30 -0.5 DE). El examen físico evidenció facies redondas, cejas gruesas, sinofris, pestañas largas, fisuras palpebrales inclinadas hacia abajo, hipertelorismo ocular, filtrum largo, pliegues de Dennis Morgan y excesivo vello facial grueso principalmente en región frontal (<xref ref-type="fig" rid="f4">Fig. 1</xref>). Hipertricosis en dorso y región mamilar (<xref ref-type="fig" rid="f5">Fig. 2</xref>). Hipotonía generalizada leve, pies anchos. A nivel comportamental se manifiesta con irritabilidad persistente, no hiperactividad.</p>
<p>
<fig id="f4" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Apariencia facial. Características evidentes en una vista de perfil frontal a la edad de un año: hipertricosis frontal, línea de implantación anterior del cabello baja, cejas gruesas, sinofris, pestañas largas, hipertelorismo, ptosis izquierda, pliegues epicánticos, fisuras palpebrales inclinadas hacia abajo, orejas de implantación baja y puente nasal ancho y deprimido. </title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf4"></graphic></fig>
</p>
<p>
<fig id="f5" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Apariencia corporal. Hipertricosis generalizada, más prominente a nivel de línea media y región dorsal baja. </title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf5"></graphic></fig>
</p>
<p>Se realizó el estudio parte de genética de secuenciación exómica utilizando el enfoque de trío (CeGaT-GmbH, https://www.cegat.de/en/). Las regiones codificantes fueron enriquecidas usando la tecnología en solución de Agilent y fueron secuenciadas usando el sistema HiSeq2500/4000 de Illumina. Los datos de salida de Illumina HiSeq se convirtieron de un archivo bcl a un archivo FastQ por el software Illumina CASAVA 1.8, y fueron asignados por el programa Burrows Wheeler Aligner a la secuencia haploide del genoma humano de referencia (GRCh38 https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38). <italic>Whole exome sequencing</italic> (WES) reveló una nueva variante patogénica de novo de tipo frameshift: c. 4177dupA (p. Ile1393Asn<italic>fs</italic> * 14) en <italic>KMT2A</italic> (v1. NM_001197104.1), la cual no fue identificada en ninguno de los padres y no se encuentra reportada en las bases de datos poblacionales. Esta variante genera un cambio en el marco de lectura que resulta en el truncamiento prematuro de la proteína o degradación del ARN mensajero, y fue confirmada mediante secuenciación Sanger. Esta variante es compatible con el diagnóstico de Síndrome de Wiedemann-Steiner. No se identificaron más variantes en este estudio. </p>
<p>Basado en la <italic>ACMG variant interpretation guideline</italic><xref ref-type="bibr" rid="B10"><sup>10</sup></xref> la variante se clasifica como patogénica (Criterios PVS1, PS2, PM2 y PP3). Los softwares bioinformáticas de predicción de variantes SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org</ext-link>/), FATHMM (<ext-link ext-link-type="uri" xlink:href="http://fathmm.biocompute.org.uk/">http://fathmm.biocompute.org.uk/</ext-link>) y Polymorphism Phenotyping v2 (Polyphen-2 <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>) la clasifican con efecto deletéreo dada la alta conservación de la posición en vertebrados. </p>
<p>Se explicó a la familia la herencia <italic>de novo</italic> de la mutación que implica un riesgo de recurrencia que oscila entre el 3 al 5% en otra gestación <xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. El plan de seguimiento de la paciente incluyó estudios renales y cardiacos anuales para valorar otras manifestaciones asociadas a la patología que pueden no estar presentes por la edad del diagnóstico y un seguimiento neurológico por neuropediatria que debe incluir una intervención de la hipotonía y el compromiso intelectual asociados con una terapia integral. </p>
<p>Se obtuvo el consentimiento informado de los padres de la paciente para la publicación del reporte de caso y las imágenes acompañantes. </p>
</sec>
<sec sec-type="discussion">
<title>Discusión </title>
<p>La secuenciación del exoma ha revolucionado el estudio genético de enfermedades monogénicas en la última década<italic>.</italic> Esta herramienta diagnóstica permite la secuenciación del exoma completo (≈3% del genoma) de manera eficiente en términos de costo y tiempo para la identificación de la causa de síndromes genéticos dismorfológicos con alta heterogeneidad clínica y genética ayudando a comprender los mecanismos moleculares de las patologías con herencia mendeliana <xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. Este método ha permitido también el descubrimiento de nuevos genes y síndromes involucrados en enfermedades humanas que permanecían en odisea diagnóstica y en la actualidad presenta un rendimiento diagnostico mayor al 25% en el ejercicio de la práctica médica de la genética <xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. </p>
<p>Uno de los síndromes nuevos identificados mediante la secuenciación de exoma es el SWS el cual comparte algunas características clínicas solapantes con otros síndromes que cursan con hipertricosis y que se conoce solo desde el 2012 <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref>. El gen <italic>KMT2A</italic> ha aparecido como un candidato causante de este síndrome en estudios con gran tamaño de muestra que validan la utilidad clínica de la secuenciación de nueva generación<xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref>. El predominio de unos genes recientemente caracterizados de manera recurrente entre los hallazgos genéticos en estos estudios, se debe probablemente a la falta de pruebas clínicas disponibles, ya sea por análisis del gen de manera individual o por un panel multigen, para la mayoría de estos nuevos loci asociados con la enfermedad <xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
<p>El fenotipo asociado al SWS es amplio por lo que el diagnóstico es un desafío. En la paciente reportada en nuestro reporte de caso, las características faciales parecen ser similares a los pacientes reportados en otros estudios donde se incluye sinofris, pestañas largas, hipertelorismo ocular y filtrum largo <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref> las cuales se acentúan más con la edad <xref ref-type="bibr" rid="B16"><sup>16</sup></xref>, pero son evidentes en pacientes con un año de edad. A nivel corporal es evidente la hipertricosis generalizada, prominentemente a nivel dorsal lo cual se ha reportado en más del 80% de los pacientes <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. La hipertricosis cubiti asociada con este síndrome y considerada la característica más prominente no está presente en nuestra paciente, tampoco hay historia de retraso del crecimiento prenatal como han informado otros autores <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>, no presentó microcefalia como se encuentra en el 50% de los pacientes con SWS <xref ref-type="bibr" rid="B5"><sup>5</sup></xref>. Las características fenotípicas de nuestra paciente se resumen en la <xref ref-type="table" rid="t3">Tabla 1</xref><bold>.</bold></p>
<p>
<table-wrap id="t3" orientation="portrait" position="float"><label>Tabla 1</label><caption><title>Resumen de las características fenotípicas presentes en más del 60% de pacientes con SWS. </title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1">Características fenotípicas presentes en la paciente</th><th align="center" colspan="1" rowspan="1">% de pacientes con SWS que presentan la característica</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Retardo del crecimiento postnatal</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Retraso en el desarrollo psicomotor </td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Retardo mental variable</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Puente nasal deprimido</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Nariz bulbosa</td><td align="center" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Pestañas largas</td><td align="center" colspan="1" rowspan="1">94.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Puente nasal ancho</td><td align="center" colspan="1" rowspan="1">89.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Fisuras palpebrales inclinadas hacia abajo</td><td align="center" colspan="1" rowspan="1">88.9</td></tr><tr><td align="left" colspan="1" rowspan="1">Cabello grueso</td><td align="center" colspan="1" rowspan="1">85.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Almohadillas digitales prominentes</td><td align="center" colspan="1" rowspan="1">83.3</td></tr><tr><td align="left" colspan="1" rowspan="1">Hipertricosis dorsal</td><td align="center" colspan="1" rowspan="1">83.3</td></tr><tr><td align="left" colspan="1" rowspan="1">Línea de implantación del cabello baja</td><td align="center" colspan="1" rowspan="1">75.0</td></tr><tr><td align="left" colspan="1" rowspan="1">Punta nasal ancha</td><td align="center" colspan="1" rowspan="1">73.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Cejas gruesas</td><td align="center" colspan="1" rowspan="1">71.4</td></tr><tr><td align="left" colspan="1" rowspan="1">Hipertelorismo</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Hipotonía</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Ptosis</td><td align="center" colspan="1" rowspan="1">63.6</td></tr></tbody><tbody><tr><td align="left" colspan="1" rowspan="1">Características fenotípicas no presentes en la paciente</td><td align="center" colspan="1" rowspan="1">% de pacientes con SWS que presentan la característica</td></tr><tr><td align="left" colspan="1" rowspan="1">Paladar alto</td><td align="center" colspan="1" rowspan="1">88.3</td></tr><tr><td align="left" colspan="1" rowspan="1">Retardo del crecimiento prenatal</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Columela corta</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Macroglosia</td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Pliegue palmar único </td><td align="center" colspan="1" rowspan="1">66.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Manos y pies pequeños</td><td align="center" colspan="1" rowspan="1">63.6</td></tr><tr><td align="left" colspan="1" rowspan="1">Clinodactilia</td><td align="center" colspan="1" rowspan="1">60.0</td></tr></tbody></table></table-wrap>
</p>
<p>Las manifestaciones neurológicas reportadas en SWS incluyen retraso mental y retraso del desarrollo psicomotor en el 100% de los pacientes e hipotonía en el 66.7%, ambas presentes en la paciente, quien además cursa con retraso del desarrollo del habla. No es posible debido a su edad valorar coeficiente intelectual. El comportamiento se caracteriza por irritabilidad sin ser claro un componente de hiperactividad, lo cual se ha reportado en cerca del 20% de los pacientes con este síndrome, quienes cursan con trastornos del comportamiento como heteroagresión, hiperactividad y rasgos autistas <xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. La paciente cursa además con luxación congénita de la cadera que se ha reportado en el 34% de los pacientes con SWS <xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Se descartó mediante estudios otras características reportadas en los pacientes como alteraciones en la alimentación (58% de los pacientes) y otras menos frecuentes como alteraciones del sistema urinario (34.0% de pacientes) y anomalías cardiacas (31.3% de los pacientes) importantes por su asociación con alta tasa de morbilidad <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref>.</p>
<p>El gen afectado KMT2A (lisina metiltransferasa 2A) codifica una histona metiltransferasa relacionada con la regulación de la expresión génica, mediante la modificación de la compactación del DNA en el desarrollo temprano y la hematopoyesis en el proceso de regulación de transcripción mediada por la remodelación de cromatina y se expresa ampliamente en la mayoría de los tejidos humanos <xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref> contiene 36 exones y dos transcritos que codifican diferentes isoformas (Ref Seq 2010). Hasta el momento todas las mutaciones reportadas causantes de WDSTS son <italic>de novo</italic>, y con cada reporte clínico se reporta también generalmente una nueva variante. La mayoría de las mutaciones son de tipo <italic>nonsense, frameshit, splice site</italic> o <italic>exon deletion</italic> las cuales terminan en un transcrito (ARN mensajero) truncado. La mutación aquí reportada c. 4177dupA (p. Ile1393Asn<italic>fs</italic> * 14) no está presente en 1,000 Genomes Project, ExAC, EVSor in-house database, y no ha sido reportada en la literatura. Las mutaciones de tipo frameshift, como esta constituyen un criterio moderado para la clasificación de patogenicidad de variantes de la ACMG ya que modifican la longitud de la proteína, al insertar codones de parada prematuros con el corrimiento del marco de lectura, por lo que normalmente se relacionan con fenotipos severos en enfermedades monogénicas <xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. </p>
<p>Las variantes patogénicas del gen KMT2A causantes del SWS se han distribuida a lo largo de todo el gen, todas localizadas antes del dominio FYRC que es importante para el reconocimiento de la proteína posterior al clivaje. Más de la mitad de las mutaciones se han ubicado en el exón 3 y 27, los cuales son los dos exones más largos del gen, sin embargo, no es claro el comportamiento de sitios <italic>hot spot</italic> mutacional <xref ref-type="bibr" rid="B5"><sup>5</sup></xref>. La paciente aquí reportada tiene una variante en el exón 9, entre dos dominios conservados de esta proteína como lo son el dominio rico en cisteína CXXC homologo a DNA meltil transferasa y el motivo PHD (Plant homeodomain Finger) (<xref ref-type="fig" rid="f6">Fig. 3</xref>) los cuales permiten la unión específica a motivos CpG no metilados del DNA, esencial para el reconocimiento génico, transactivación y transformación asociado a las proteínas MLL <xref ref-type="bibr" rid="B19"><sup>19</sup></xref>. Existe solo un paciente reportado por Mendelsohn <italic>et al</italic><xref ref-type="bibr" rid="B20"><sup>20</sup></xref> con una mutación similar, en ese caso una deleción intragénica que implicaba los exones 2-10 (<xref ref-type="table" rid="t4">Tabla 2</xref>), el cual llamativamente presentaba infecciones recurrentes del tracto urinario y alteraciones renales. Nuestra paciente ha tenido dos infecciones urinarias, una de ellas complicada con pielonefritis a los 20 meses por lo cual requirió valoración por Nefrología, quienes descartaron alteración renal en las imágenes realizadas, sin embargo, existe una recomendación actual para el seguimiento con Ecografía renal de manera rutinaria en los pacientes con diagnóstico de SWS <xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. La alteración de la paciente, en estado heterocigoto con herencia autosómica dominante se comporta como un alelo nulo, con una proteína truncada prematuramente que interfiere con la proteína normal y que es similar a lo reportado en la literatura donde normalmente hay un alelo nulo o con pérdida de función con efecto dominante negativo sobre el alelo normal <xref ref-type="bibr" rid="B6"><sup>6</sup></xref>.</p>
<p>
<fig id="f6" orientation="portrait" position="float"><label>Figura 3</label><caption><title><bold>A.</bold> Localización de la mutación en KMT2A reportada. Electroferograma del exón 9 del gen KMT2A que evidencia la duplicación de la Adenina (flecha azul) en la posición 4177 c.4177dupA, la cual tiene un efecto de corrimiento de marco de lectura, generando un codón de parada prematura 13 posiciones más adelante (Recuadro rojo). B. Posición a nivel de la proteína: La mutación causa una terminación prematura de la proteína antes de la traducción de la región c-terminal (Flecha negra) que contiene el dominio BD, dominio de transactivación y dominio SET, así como los motivos PHD esenciales para el reconocimiento génico, transactivación y transformación asociado a la proteína y los motivos FRYN, FYRC y Win.</title></caption><graphic xlink:href="1657-9534-cm-50-01-00040-gf6"></graphic></fig>
</p>
<p>
<table-wrap id="t4" orientation="portrait" position="float"><label>Tabla 2</label><caption><title>Resumen de las mutaciones en KMT2A reportadas en pacientes con SWS. </title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Pacientes</th><th align="left" colspan="1" rowspan="1">Cambio en el aminoácido </th><th align="justify" colspan="1" rowspan="1">Region afectada del gen </th><th align="left" colspan="1" rowspan="1">Etnia </th><th align="justify" colspan="1" rowspan="1">Autor</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">WDST1</td><td align="justify" colspan="1" rowspan="1">p.V2936* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">No reportada</td><td align="justify" colspan="1" rowspan="5">Jones et al. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">WDST2</td><td align="justify" colspan="1" rowspan="1">p.L2756* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">WDST3</td><td align="justify" colspan="1" rowspan="1">p.S2305Lfs*2 </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">WDST5</td><td align="justify" colspan="1" rowspan="1">p.R2382*</td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">WDST6</td><td align="justify" colspan="1" rowspan="1">p.K1534* </td><td align="justify" colspan="1" rowspan="1">Exón 13</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 1</td><td align="justify" colspan="1" rowspan="1">p.C1448R </td><td align="justify" colspan="1" rowspan="1">Exón 11</td><td align="left" colspan="1" rowspan="1">Mexicano</td><td align="justify" colspan="1" rowspan="2">Strom et al. <xref ref-type="bibr" rid="B7"><sup>7</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 2</td><td align="justify" colspan="1" rowspan="1">c.4086+1G&gt;A </td><td align="justify" colspan="1" rowspan="1">Intron 8</td><td align="left" colspan="1" rowspan="1">Caucásico</td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">chr11:118,339,487-118,355,089del </td><td align="justify" colspan="1" rowspan="1">Exón 2 to 10</td><td align="left" colspan="1" rowspan="1">Hispánico</td><td align="justify" colspan="1" rowspan="1">Mendelson et al. <xref ref-type="bibr" rid="B20"><sup>20</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">P1</td><td align="justify" colspan="1" rowspan="1">p.G2422* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">No reportada</td><td align="justify" colspan="1" rowspan="2">Zemojtel et al.<xref ref-type="bibr" rid="B21"><sup>21</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">P8</td><td align="justify" colspan="1" rowspan="1">p.E3448fs*7 </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">p.R2127* </td><td align="justify" colspan="1" rowspan="1">Exón 26</td><td align="left" colspan="1" rowspan="1">No reportada</td><td align="justify" colspan="1" rowspan="1">Calvel et al. <xref ref-type="bibr" rid="B22"><sup>22</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Gemelo 1</td><td align="justify" colspan="1" rowspan="1">p.R1083* </td><td align="justify" colspan="1" rowspan="1">Exón 4</td><td align="left" colspan="1" rowspan="1">Caucásico</td><td align="justify" colspan="1" rowspan="2">Dunkerton et al. <xref ref-type="bibr" rid="B18"><sup>18</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Gemelo 2</td><td align="justify" colspan="1" rowspan="1">p.R1083* </td><td align="justify" colspan="1" rowspan="1">Exón 4</td><td align="left" colspan="1" rowspan="1">
</td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">p.R1636* </td><td align="justify" colspan="1" rowspan="1">Exón 15</td><td align="left" colspan="1" rowspan="1">Árabe</td><td align="justify" colspan="1" rowspan="1">Steel et al. <xref ref-type="bibr" rid="B23"><sup>23</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 1</td><td align="justify" colspan="1" rowspan="1">p.R2480* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">Japonés </td><td align="justify" colspan="1" rowspan="6">Miyake et al. <xref ref-type="bibr" rid="B24"><sup>24</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 2</td><td align="justify" colspan="1" rowspan="1">p.Q2261* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">Japonés</td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 3</td><td align="justify" colspan="1" rowspan="1">p.C1189Y </td><td align="left" colspan="1" rowspan="1">Exón 5</td><td align="left" colspan="1" rowspan="1">Australiano</td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 4</td><td align="justify" colspan="1" rowspan="1">p.Pro280Thr </td><td align="left" colspan="1" rowspan="1">Exón 3</td><td align="left" colspan="1" rowspan="1">Japonés</td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 5</td><td align="justify" colspan="1" rowspan="1">p.V347Lfs*53</td><td align="justify" colspan="1" rowspan="1">Exón 3</td><td align="left" colspan="1" rowspan="1">Japonés</td></tr><tr><td align="left" colspan="1" rowspan="1">Paciente 6</td><td align="justify" colspan="1" rowspan="1">p.L717Cfs*39 </td><td align="justify" colspan="1" rowspan="1">Exon 3</td><td align="left" colspan="1" rowspan="1">Japonés</td></tr><tr><td align="left" colspan="1" rowspan="1">CdLS 3</td><td align="justify" colspan="1" rowspan="1">p.R745* </td><td align="justify" colspan="1" rowspan="1">Exón 3</td><td align="left" colspan="1" rowspan="1">Turco</td><td align="justify" colspan="1" rowspan="1">Yuan et al. <xref ref-type="bibr" rid="B25"><sup>25</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">p.C1161G </td><td align="justify" colspan="1" rowspan="1">Exón 5</td><td align="left" colspan="1" rowspan="1">Italiano</td><td align="justify" colspan="1" rowspan="1">Stellacci et al. <xref ref-type="bibr" rid="B26"><sup>26</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">A.II-5</td><td align="justify" colspan="1" rowspan="1">p.Q2803* </td><td align="justify" colspan="1" rowspan="1">Exón 27</td><td align="left" colspan="1" rowspan="1">Chino</td><td align="justify" colspan="1" rowspan="2">Sun et al. (<xref ref-type="bibr" rid="B5">5</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">B.II-1</td><td align="justify" colspan="1" rowspan="1">p.Q819* </td><td align="justify" colspan="1" rowspan="1">Exón 3</td><td align="left" colspan="1" rowspan="1">Chino</td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">p. Pro51Argfs*84 </td><td align="justify" colspan="1" rowspan="1">Exón 1</td><td align="left" colspan="1" rowspan="1">No reportada</td><td align="justify" colspan="1" rowspan="1">Argawall et al. <xref ref-type="bibr" rid="B27"><sup>27</sup></xref></td></tr><tr><td align="left" colspan="1" rowspan="1">
</td><td align="justify" colspan="1" rowspan="1">p. Ile1393Asn<italic>fs</italic>*14 </td><td align="justify" colspan="1" rowspan="1">Exón 9</td><td align="left" colspan="1" rowspan="1">Colombiano</td><td align="justify" colspan="1" rowspan="1">Este reporte</td></tr></tbody></table></table-wrap>
</p>
<p>En conclusión, se reporta por primera vez una paciente de origen colombiano con una variante patogénica de tipo frameshift no reportada en KMT2A. Sus características son similares fenotípicamente a lo reportado en la literatura, con una historia clínica de episodios de infección urinaria sin alteración renal, lo cual parece relacionarse con la actividad metil transferasa de la proteína ubicada en los dominios afectados por la mutación aquí reportada. Esta sería una aproximación a la correlación genotipo-fenotipo que se propone para el SWS, donde además de la hipertricosis se debe analizar el compromiso neurológico y renal. Las características más prominentes del SWS que pueden servir como criterio diagnóstico son: hipertricosis generalizada, retardo del crecimiento postnatal, retraso del desarrollo psicomotor y fenotipo facial distintivo (cabello y cejas gruesas, hipertelorismo, fisuras palpebrales inclinadas hacia abajo y pestañas largas). Estas características están presentes en más del 70% de los pacientes reportados en la literatura mundial. </p>
</sec>
</body>
</sub-article>
</article>
</pmc-articleset>